Zydus gets USFDA approval for Indomethacin suppository with CGT designation
The company has been granted 180-day CGT exclusivity to market this product
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
rheumatoid arthritis
Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab
This is the company’s fourth biosimilar launch in recent times
AYUSH Ministry to conduct clinical trial in Ayurveda for rheumatoid arthritis
This project is one of the first multi-centre phase-III double-blind double-dummy clinical trials on the efficacy of Ayurveda in…
Gilead, Galapagos amend commercialisation and development pact for Jyseleca (filgotinib)
Under the new arrangement, Galapagos will assume sole responsibility in Europe for filgotinib in RA, Gilead to receive royalties…
Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis
Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution
Lupin launches Leflunomide Tablets USP
These tablets are indicated for the treatment of adults with active rheumatoid arthritis
Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India
It is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis
Dr Reddy’s Laboratories launches penicillamine capsules in US
It is a chelating agent used in the treatment of Wilson’s disease and to reduce cystine excretion in cystinuria and to treat…
Lupin and Mylan launch Nepexto, biosimilar etanercept in German market
Etanercept was first approved for the treatment of rheumatoid arthritis in Germany in 2000 and since then has offered an effective…
US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib
The US drug regulator has issued a complete response letter requesting data from the MANTA and MANTA-RAy studies and expressing…